Loading...

You're on the old version of Simply Wall St. We will no longer be supporting this site, so we recommend you switch to our brand new platform.

SIGA Technologies

Nasdaq:SIGA
Snowflake Description

Mediocre balance sheet with weak fundamentals.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
SIGA
Nasdaq
$418M
Market Cap
  1. Home
  2. US
  3. Pharmaceuticals & Biotech
Company description

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security markets in the United States. The last earnings update was 34 days ago. More info.


Add to Portfolio Compare Print
SIGA Share Price and Events
7 Day Returns
13%
NasdaqGM:SIGA
3.1%
US Pharmaceuticals
-2.6%
US Market
1 Year Returns
-8.2%
NasdaqGM:SIGA
-3.4%
US Pharmaceuticals
-13.3%
US Market
SIGA Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
SIGA Technologies (SIGA) 13% 1% 1% -8.2% 60.6% 211.5%
US Pharmaceuticals 3.1% -4.8% -8.7% -3.4% 8.9% 4.8%
US Market -2.6% -15.2% -22.2% -13.3% 5.7% 17.2%
1 Year Return vs Industry and Market
  • SIGA underperformed the Pharmaceuticals industry which returned -3.4% over the past year.
  • SIGA outperformed the Market in United States of America which returned -13.3% over the past year.
Price Volatility
SIGA
Industry
5yr Volatility vs Market

SIGA Value

 Is SIGA Technologies undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for SIGA Technologies. This is due to cash flow or dividend data being unavailable. The share price is $5.14.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for SIGA Technologies's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are SIGA Technologies's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
NasdaqGM:SIGA PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-12-31) in USD $-0.09
NasdaqGM:SIGA Share Price ** NasdaqGM (2020-04-07) in USD $5.14
United States of America Pharmaceuticals Industry PE Ratio Median Figure of 24 Publicly-Listed Pharmaceuticals Companies 20.1x
United States of America Market PE Ratio Median Figure of 2,946 Publicly-Listed Companies 12.49x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of SIGA Technologies.

NasdaqGM:SIGA PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= NasdaqGM:SIGA Share Price ÷ EPS (both in USD)

= 5.14 ÷ -0.09

-57.52x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • SIGA Technologies is loss making, we can't compare its value to the US Pharmaceuticals industry average.
  • SIGA Technologies is loss making, we can't compare the value of its earnings to the United States of America market.
Price based on expected Growth
Does SIGA Technologies's expected growth come at a high price?
Raw Data
NasdaqGM:SIGA PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -57.52x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
Not available
United States of America Pharmaceuticals Industry PEG Ratio Median Figure of 21 Publicly-Listed Pharmaceuticals Companies 1.91x
United States of America Market PEG Ratio Median Figure of 2,010 Publicly-Listed Companies 0.89x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for SIGA Technologies, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on SIGA Technologies's assets?
Raw Data
NasdaqGM:SIGA PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-12-31) in USD $1.20
NasdaqGM:SIGA Share Price * NasdaqGM (2020-04-07) in USD $5.14
United States of America Pharmaceuticals Industry PB Ratio Median Figure of 181 Publicly-Listed Pharmaceuticals Companies 2.29x
United States of America Market PB Ratio Median Figure of 5,158 Publicly-Listed Companies 1.22x
NasdaqGM:SIGA PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= NasdaqGM:SIGA Share Price ÷ Book Value per Share (both in USD)

= 5.14 ÷ 1.20

4.27x

* Primary Listing of SIGA Technologies.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • SIGA Technologies is overvalued based on assets compared to the US Pharmaceuticals industry average.
X
Value checks
We assess SIGA Technologies's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Pharmaceuticals industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Pharmaceuticals industry average (and greater than 0)? (1 check)
  5. SIGA Technologies has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

SIGA Future Performance

 How is SIGA Technologies expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as SIGA Technologies has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.

Show me the analysis anyway

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
27.3%
Expected Pharmaceuticals industry annual growth in earnings.
Earnings growth vs Low Risk Savings
Is SIGA Technologies expected to grow at an attractive rate?
  • Unable to compare SIGA Technologies's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare SIGA Technologies's earnings growth to the United States of America market average as no estimate data is available.
  • Unable to compare SIGA Technologies's revenue growth to the United States of America market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
NasdaqGM:SIGA Future Growth Rates Data Sources
Data Point Source Value (per year)
United States of America Pharmaceuticals Industry Earnings Growth Rate Market Cap Weighted Average 27.3%
United States of America Pharmaceuticals Industry Revenue Growth Rate Market Cap Weighted Average 5%
United States of America Market Earnings Growth Rate Market Cap Weighted Average 13.4%
United States of America Market Revenue Growth Rate Market Cap Weighted Average 7%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
NasdaqGM:SIGA Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
NasdaqGM:SIGA Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2019-12-31 27 -18 -7
2019-09-30 24 -8 50
2019-06-30 487 78 439
2019-03-31 486 77 435
2018-12-31 477 69 422
2018-09-30 477 64 359
2018-06-30 7 -30 -39
2018-03-31 9 -26 -39
2017-12-31 12 -18 -36
2017-09-30 18 -35 -36
2017-06-30 21 -84 -36
2017-03-31 19 -108 -38

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if SIGA Technologies is high growth as no earnings estimate data is available.
  • Unable to determine if SIGA Technologies is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
NasdaqGM:SIGA Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from SIGA Technologies Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NasdaqGM:SIGA Past Financials Data
Date (Data in USD Millions) EPS *
2019-12-31 -0.09
2019-09-30 0.61
2019-06-30 5.43
2019-03-31 5.41
2018-12-31 5.28
2018-09-30 4.52
2018-06-30 -0.49
2018-03-31 -0.50
2017-12-31 -0.46
2017-09-30 -0.48
2017-06-30 -0.52
2017-03-31 -0.60

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if SIGA Technologies will efficiently use shareholders’ funds in the future without estimates of Return on Equity.

Next steps:

  1. Take a look at our analysis of SIGA’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  2. SIGA Technologies's future outlook can be gauged by looking at industry trends and market size, and determining how well-positioned the company is compared to its competitors. Take a look at other high-growth Pharmaceuticals & Biotech companies here
  3. SIGA Technologies's competitive advantages and company strategy can generally be found in its financial reports archived here.
  4. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Future performance checks
We assess SIGA Technologies's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United States of America market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United States of America market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
SIGA Technologies has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

SIGA Past Performance

  How has SIGA Technologies performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare SIGA Technologies's growth in the last year to its industry (Pharmaceuticals).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • SIGA Technologies does not make a profit even though their year on year earnings growth rate was positive over the past 5 years.
  • Unable to compare SIGA Technologies's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare SIGA Technologies's 1-year growth to the US Pharmaceuticals industry average as it is not currently profitable.
Earnings and Revenue History
SIGA Technologies's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from SIGA Technologies Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NasdaqGM:SIGA Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-12-31 26.74 -7.24 13.25
2019-09-30 24.05 49.65 13.58
2019-06-30 487.01 438.91 13.50
2019-03-31 485.76 435.02 12.99
2018-12-31 477.05 421.81 12.88
2018-09-30 476.90 359.11 12.33
2018-06-30 7.21 -38.75 12.31
2018-03-31 8.82 -39.20 12.49
2017-12-31 12.27 -36.24 12.30
2017-09-30 18.01 -36.37 13.46
2017-06-30 21.28 -35.80 13.25
2017-03-31 18.92 -37.86 13.93
2016-12-31 14.99 -39.70 13.71
2016-09-30 12.02 -49.35 11.87
2016-06-30 8.69 -45.74 11.31
2016-03-31 8.25 -42.75 10.16
2015-12-31 8.18 -39.45 10.58
2015-09-30 4.83 -38.41 10.44
2015-06-30 4.60 -272.86 12.43
2015-03-31 3.78 -269.23 12.64
2014-12-31 3.14 -265.46 12.65
2014-09-30 3.23 -250.75 13.93
2014-06-30 4.43 -15.57 12.74
2014-03-31 4.74 -15.68 13.10
2013-12-31 5.52 -17.18 13.12
2013-09-30 7.10 -15.46 11.90
2013-06-30 7.10 -13.61 11.92

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if SIGA Technologies has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • SIGA Technologies used its assets less efficiently than the US Pharmaceuticals industry average last year based on Return on Assets.
  • It is difficult to establish if SIGA Technologies improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess SIGA Technologies's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Pharmaceuticals industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
SIGA Technologies has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

SIGA Health

 How is SIGA Technologies's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up SIGA Technologies's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • SIGA Technologies is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • SIGA Technologies's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of SIGA Technologies's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is covered by short term assets, assets are 2.2x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from SIGA Technologies Company Filings, last reported 3 months ago.

NasdaqGM:SIGA Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-12-31 97.78 80.04 65.25
2019-09-30 102.87 78.91 78.10
2019-06-30 103.45 77.78 100.26
2019-03-31 106.07 76.66 102.09
2018-12-31 102.91 75.55 100.65
2018-09-30 52.47 74.41 103.99
2018-06-30 -341.32 73.28 10.58
2018-03-31 -334.62 72.16 13.93
2017-12-31 -323.14 71.05 19.86
2017-09-30 -312.83 69.92 25.80
2017-06-30 -303.41 68.78 30.87
2017-03-31 -296.14 67.66 30.10
2016-12-31 -287.42 66.55 28.70
2016-09-30 -313.16 0.00 20.49
2016-06-30 -304.07 0.00 78.02
2016-03-31 -294.68 0.00 104.06
2015-12-31 -284.43 0.00 112.71
2015-09-30 -264.67 0.00 129.29
2015-06-30 -259.39 0.00 115.66
2015-03-31 -253.20 0.00 95.55
2014-12-31 -246.50 1.99 99.71
2014-09-30 -227.98 2.48 104.68
2014-06-30 11.57 2.98 99.03
2014-03-31 13.94 3.47 107.07
2013-12-31 16.98 3.96 91.31
2013-09-30 19.32 4.45 105.19
2013-06-30 23.41 11.94 32.96
  • SIGA Technologies's level of debt (81.9%) compared to net worth is high (greater than 40%).
  • SIGA Technologies had negative shareholder equity 5 years ago, it is now positive therefore their debt level has improved.
  • Operating cash flow is negative therefore debt is not well covered.
  • Unable to confirm if the interest payments on SIGA Technologies's debt are well covered by earnings due to lack of past financial data.
X
Financial health checks
We assess SIGA Technologies's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. SIGA Technologies has a total score of 3/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

SIGA Dividends

 What is SIGA Technologies's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from SIGA Technologies dividends.
If you bought $2,000 of SIGA Technologies shares you are expected to receive $0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate SIGA Technologies's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate SIGA Technologies's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
NasdaqGM:SIGA Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
United States of America Pharmaceuticals Industry Average Dividend Yield Market Cap Weighted Average of 11 Stocks 2.9%
United States of America Market Average Dividend Yield Market Cap Weighted Average of 1935 Stocks 3%
United States of America Minimum Threshold Dividend Yield 10th Percentile 1.1%
United States of America Bottom 25% Dividend Yield 25th Percentile 2%
United States of America Top 25% Dividend Yield 75th Percentile 5.7%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as SIGA Technologies has not reported any payouts.
  • Unable to verify if SIGA Technologies's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of SIGA Technologies's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as SIGA Technologies has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess SIGA Technologies's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.1%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can SIGA Technologies afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. SIGA Technologies has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

SIGA Management

 What is the CEO of SIGA Technologies's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Phil Gomez
COMPENSATION $1,545,000
AGE 52
TENURE AS CEO 3.5 years
CEO Bio

Dr. Phillip Louis Gomez III, also known as Phil, PhD, has been Chief Executive Officer of SIGA Technologies, Inc. since October 13, 2016 and has been its Director since December 6, 2016. Dr. Gomez was a Principal of PricewaterhouseCoopers LLP in the Pharma & Life Sciences Management Consulting Practice. Prior to joining PwC and PRTM, Dr. Gomez worked at the National Institutes of Health in Bethesda, MD, where he established the Vaccine Production Program at the Vaccine Research Center in 2001. During his six-year tenure, his group manufactured more than forty bulk pharmaceutical compounds and more than fifteen candidate vaccines through innovative collaborations with industry to advance the development of vaccines against HIV, Ebola, West Nile Virus, Marburg, Severe Acute Respiratory System (SARS), and Influenza. Dr. Gomez has advised companies, governments, academic medical centers and foundations in the fields of Biodefense and Global Public Health. Prior to NIH, Dr. Gomez spent nearly a decade in the pharmaceutical industry at Abbott Laboratories, Sanofi Pasteur and Baxter Healthcare leading process/product development organizations as well as project teams for product development. In 2007, Dr. Gomez earned the NIH Director's Award for the establishment of the vaccine pilot plant and for the rapid production of a candidate pandemic influenza vaccine. Dr. Gomez holds a Bachelor of Arts degree from Dartmouth College, a Master of Science and a Doctor of Philosophy in chemical engineering from Lehigh University and a Master of Business Administration from the Smith School of Business at the University of Maryland.

CEO Compensation
  • Phil's compensation has been consistent with company performance over the past year, both up more than 20%.
  • Phil's remuneration is lower than average for companies of similar size in United States of America.
Management Team Tenure

Average tenure and age of the SIGA Technologies management team in years:

6.6
Average Tenure
53.5
Average Age
  • The average tenure for the SIGA Technologies management team is over 5 years, this suggests they are a seasoned and experienced team.
Management Team

Phil Gomez

TITLE
CEO & Director
COMPENSATION
$2M
AGE
52
TENURE
3.5 yrs

Daniel Luckshire

TITLE
Executive VP
COMPENSATION
$1M
AGE
48
TENURE
9.2 yrs

Dennis Hruby

TITLE
VP & Chief Scientific Officer
COMPENSATION
$1M
AGE
67
TENURE
19.8 yrs

Robin Abrams

TITLE
General Counsel & Chief Administrative Officer
COMPENSATION
$1M
AGE
55
TENURE
4 yrs
Board of Directors Tenure

Average tenure and age of the SIGA Technologies board of directors in years:

11.1
Average Tenure
66
Average Age
  • The average tenure for the SIGA Technologies board of directors is over 10 years, this suggests they are a seasoned and experienced board.
Board of Directors

Eric Rose

TITLE
Chairman of the Board
COMPENSATION
$603K
AGE
68
TENURE
13.3 yrs

Phil Gomez

TITLE
CEO & Director
COMPENSATION
$2M
AGE
52
TENURE
3.3 yrs

Chip Marshall

TITLE
Independent Director
COMPENSATION
$145K
AGE
66
TENURE
11.1 yrs

Michael Plansky

TITLE
Independent Director
COMPENSATION
$149K
AGE
69
TENURE
2.9 yrs

Julie Kane

TITLE
Independent Director
AGE
60
TENURE
0.9 yrs

Thomas Constance

TITLE
Independent Director
COMPENSATION
$135K
AGE
83
TENURE
19 yrs

Paul Savas

TITLE
Independent Director
COMPENSATION
$137K
AGE
55
TENURE
16.3 yrs

Jim Antal

TITLE
Independent Director
COMPENSATION
$137K
AGE
68
TENURE
15.4 yrs

Jeff Kindler

TITLE
Independent Director
COMPENSATION
$132K
AGE
63
TENURE
7.1 yrs
Who owns this company?
Recent Insider Trading
  • More shares have been bought than sold by SIGA Technologies individual insiders in the past 3 months, but not in substantial volumes.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price ($) Value ($)
25. Feb 20 Buy Paul Saunders Individual 24. Feb 20 24. Feb 20 10,000 $4.58 $45,800
25. Feb 20 Buy Hutch Capital Management LLC Company 24. Feb 20 24. Feb 20 10,000 $4.58 $45,800
13. Feb 20 Sell Hutch Capital Management LLC Company 07. Jan 20 05. Feb 20 -161,075 $5.41 $0
13. Feb 20 Buy Hutch Capital Management LLC Company 03. Feb 20 11. Feb 20 124,231 $5.14 $0
13. Feb 20 Sell Esopus Creek Advisors Llc Company 12. Nov 19 10. Feb 20 -8,600 $5.18 $-39,836
13. Feb 20 Buy Esopus Creek Advisors Llc Company 11. Nov 19 07. Feb 20 32,076 $5.21 $149,674
10. Dec 19 Buy Paul Savas Individual 09. Dec 19 09. Dec 19 20,000 $4.37 $87,400
10. Dec 19 Buy Julie Kane Individual 09. Dec 19 09. Dec 19 2,500 $4.39 $10,975
10. Dec 19 Buy Phillip Gomez Individual 09. Dec 19 09. Dec 19 10,000 $4.42 $44,200
10. Dec 19 Buy Daniel Luckshire Individual 09. Dec 19 09. Dec 19 5,000 $4.39 $21,950
26. Aug 19 Buy Paul Savas Individual 23. Aug 19 23. Aug 19 10,000 $4.95 $49,500
12. Aug 19 Buy Paul Savas Individual 09. Aug 19 09. Aug 19 10,000 $5.08 $50,800
02. Jul 19 Buy Michael Bayer Individual 04. Jun 19 04. Jun 19 12,500 $5.74 $71,750
07. Jun 19 Sell James Antal Individual 05. Jun 19 05. Jun 19 -30,000 $5.70 $-171,000
07. Jun 19 Sell Dennis Hruby Individual 05. Jun 19 07. Jun 19 -50,000 $5.68 $-280,530
X
Management checks
We assess SIGA Technologies's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. SIGA Technologies has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

SIGA News

Simply Wall St News

Who Owns Most Of SIGA Technologies Inc (NASDAQ:SIGA)?

I am going to take a deep dive into SIGA Technologies Inc’s (NASDAQ:SIGA) most recent ownership structure, not a frequent subject of discussion among individual investors. … A company's ownership structure is often linked to its share performance in both the long- and short-term. … The effect of an active institutional investor with a similar ownership as a passive pension-fund can be vastly different on a company's corporate governance and accountability to shareholders.

Simply Wall St -

What You Must Know About SIGA Technologies Inc's (NASDAQ:SIGA) Market Risks

A widely-used metric to measure a stock's market risk is beta, and the broad market index represents a beta value of one. … SIGA Technologies's beta of 0.55 indicates that the stock value will be less variable compared to the whole stock market. … SIGA's beta implies it may be a stock that investors with high-beta portfolios might find relevant if they wanted to reduce their exposure to market risk, especially during times of downturns.

Simply Wall St -

Who Are SIGA Technologies Inc's (NASDAQ:SIGA) Major Shareholders?

I am going to take a deep dive into SIGA Technologies Inc’s (NASDAQ:SIGA) most recent ownership structure, not a frequent subject of discussion among individual investors. … Insider Ownership Insiders form another group of important ownership types as they manage the company's operations and decide the best use of capital. … An investor should be encouraged by the ownership of these institutions who are known to be experts in increasing efficiency, improving capital structure and opting for value-accretive policy decisions.Next Steps: While SIGA has a low level of institutional ownership, active hedge funds still hold a significant stake in the company.

Simply Wall St -

Did SIGA Technologies Inc's (NASDAQ:SIGA) Recent Earnings Growth Beat The Trend?

After reading SIGA Technologies Inc's (NASDAQ:SIGA) most recent earnings announcement (31 December 2017), I found it useful to look back at how the company has performed in the past and compare this against the latest numbers. … Check out our latest analysis for SIGA Technologies Did SIGA's recent earnings growth beat the long-term trend and the industry? … For SIGA Technologies, its most recent bottom-line (trailing twelve month) is -US$36.24M, which compared to the previous year's level, has become less negative.

Simply Wall St -

SIGA Company Info

Description

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security markets in the United States. Its lead product is TPOXX, an orally administered antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was founded in 1995 and is headquartered in New York, New York.

Details
Name: SIGA Technologies, Inc.
SIGA
Exchange: NasdaqGM
Founded: 1995
$417,740,742
81,272,518
Website: http://www.siga.com
Address: SIGA Technologies, Inc.
31 East 62nd Street,
New York,
New York, 10065,
United States
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
NasdaqGM SIGA Common Stock Nasdaq Global Market US USD 09. Sep 1997
Number of employees
Current staff
Staff numbers
41
SIGA Technologies employees.
Industry
Pharmaceuticals
Pharmaceuticals & Biotech
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2020/04/08 01:20
End of day share price update: 2020/04/07 00:00
Last earnings filing: 2020/03/05
Last earnings reported: 2019/12/31
Last annual earnings reported: 2019/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.